Masimo Co. (NASDAQ:MASI) Shares Sold by New York State Common Retirement Fund

New York State Common Retirement Fund trimmed its stake in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 10.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 47,304 shares of the medical equipment provider's stock after selling 5,514 shares during the quarter. New York State Common Retirement Fund owned 0.09% of Masimo worth $5,545,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Massachusetts Financial Services Co. MA purchased a new position in Masimo during the third quarter worth about $132,699,000. Eminence Capital LP purchased a new position in shares of Masimo in the 3rd quarter worth about $90,859,000. Hawk Ridge Capital Management LP boosted its holdings in shares of Masimo by 124.4% in the 3rd quarter. Hawk Ridge Capital Management LP now owns 567,765 shares of the medical equipment provider's stock worth $49,782,000 after purchasing an additional 314,763 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in shares of Masimo by 2.1% in the 4th quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 413,815 shares of the medical equipment provider's stock worth $48,503,000 after purchasing an additional 8,498 shares in the last quarter. Finally, Sei Investments Co. boosted its holdings in shares of Masimo by 224.5% in the 3rd quarter. Sei Investments Co. now owns 183,940 shares of the medical equipment provider's stock worth $16,128,000 after purchasing an additional 127,249 shares in the last quarter. 85.96% of the stock is currently owned by hedge funds and other institutional investors.

Masimo Trading Up 0.6 %

MASI traded up $0.75 during midday trading on Friday, reaching $137.00. 611,099 shares of the company's stock traded hands, compared to its average volume of 343,712. The firm has a fifty day moving average of $136.10 and a two-hundred day moving average of $118.80. The stock has a market capitalization of $7.25 billion, a price-to-earnings ratio of 90.73 and a beta of 0.99. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.18 and a quick ratio of 1.22. Masimo Co. has a 52 week low of $75.22 and a 52 week high of $188.76.

Masimo (NASDAQ:MASI - Get Free Report) last released its quarterly earnings results on Tuesday, February 27th. The medical equipment provider reported $1.25 EPS for the quarter, beating analysts' consensus estimates of $0.82 by $0.43. Masimo had a return on equity of 13.77% and a net margin of 3.98%. The business had revenue of $548.90 million during the quarter, compared to analyst estimates of $545.69 million. During the same quarter in the prior year, the company posted $1.32 EPS. Masimo's quarterly revenue was down 11.0% compared to the same quarter last year. On average, equities analysts anticipate that Masimo Co. will post 3.51 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on MASI shares. BTIG Research upped their price objective on Masimo from $145.00 to $166.00 and gave the stock a "buy" rating in a report on Monday, March 25th. Wells Fargo & Company upgraded Masimo from an "equal weight" rating to an "overweight" rating and upped their price objective for the stock from $117.00 to $160.00 in a report on Monday, March 25th. Piper Sandler upped their price objective on Masimo from $70.00 to $117.00 and gave the stock a "neutral" rating in a report on Monday, February 26th. Stifel Nicolaus upgraded Masimo from a "hold" rating to a "buy" rating and increased their target price for the company from $148.00 to $170.00 in a report on Monday, April 15th. Finally, StockNews.com upgraded Masimo from a "sell" rating to a "hold" rating in a report on Friday, March 29th. Five equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Masimo presently has a consensus rating of "Hold" and an average target price of $137.43.

Insider Transactions at Masimo

In other news, Director Craig B. Reynolds sold 40,000 shares of the stock in a transaction that occurred on Friday, April 26th. The stock was sold at an average price of $136.17, for a total value of $5,446,800.00. Following the completion of the transaction, the director now owns 7,406 shares of the company's stock, valued at approximately $1,008,475.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 9.70% of the company's stock.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.